Millipore’s Bioscience Division Announces Kinase Screening Agreement with Johnson & Johnson Pharmaceutical Research & Development

Billerica, Massachusetts --- January 8, 2007 --- Millipore Corporation today announced that it has signed an agreement with Johnson & Johnson Pharmaceutical Research & Development (J&JPRD), Division of Janssen Pharmaceutica N.V. for protein kinase screening using the Upstate® KinaseProfiler™ service, Millipore’s “gold standard” radiometric service. Under the terms of this agreement, J&JPRD will supply potential protein kinase inhibitors for kinase selectivity profiling against Millipore's panel of 252 protein and lipid kinases.

Millipore’s selectivity profiling services help the world’s top drug companies evaluate potential leads and guide medicinal chemistry to optimize the most promising compounds and avoid the costly development of non-specific lead candidates. The panel of kinases assembled for the KinaseProfiler service represents the largest and most disease-relevant of its kind and is under continuous improvement and expansion at Millipore’s facility in Dundee, Scotland. The direct, radiometric assay format used in the KinaseProfiler service assures robust and reliable data that is both reproducible and validated.

Millipore supports the discovery and development of new pharmaceuticals with a portfolio of products and services that expedites the discovery and evaluation of new drug candidates. This portfolio includes compound screening/profiling capabilities, multiwell filter plates, reagents, immunoassays for key targets and therapeutics categories, and regulatory compliant bioanalytical services for preclinical and clinical trials. For more information about Millipore’s drug discovery services, please contact Millipore Tech Service at 1-800-548-7853 or 951-676-8080 or visit www.millipore.com/drugdiscovery.

About Millipore

Millipore is a leading provider of products and services that improve productivity in laboratory research and bioprocessing manufacturing sites. Through its broad product portfolio, the Company drives growth through innovation and delivers higher value-added applications to the marketplace. Millipore experts have a comprehensive understanding of customers’ research, which results in superior tools, technologies and services. The Company is part of the S&P 500 index and employs approximately 5,800 employees in more than 47 offices worldwide. For additional information on Millipore Corporation, please visit www.millipore.com.

Millipore and Upstate are registered trademarks and KinaseProfiler is a trademark of Millipore Corporation.

MILLIPORE NEWS
For immediate release
Media Contact:
Karen Gobler
Communications Manager
Millipore Corporation
978-762-5294
karen_gobler@millipore.com

Find A Location

Find the Millipore office or expert closest to you.

Contact Us

We want to hear from you. Contact a specific department below or click "Suggestions and Feedback" to send your comments.